Pneumococcal Disease
📧 Sign up to get email alerts when something new happens for Pneumococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23 [Phase 4]
Phase 4 trial evaluating safety and immunogenicity of combined immunization with a COVID-19 inactivated vaccine alongside quadrivalent influ…
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old [Phase 4]
A Phase 4 trial evaluating safety and immunogenicity of revaccination with PPV23 in adults aged 60-70 years has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination [Phase 3]
Phase 3 trial assessing safety and immunogenicity of a 20-valent pneumococcal vaccine in adults 65+ with prior vaccination; study completed …
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in vaccine-naïve adults has completed; resu…
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of three lots of 20-valent pneumococcal conjugate vaccine in adults; study completed with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old) [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers aged 2-71 mo…
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Hepatitis B Vaccination in Infants [Phase 4]
A Phase 4 clinical trial update on Hepatitis B vaccination in infants has completed, with sponsor Public Health England evaluating vaccinati…
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers [Phase 3]
Phase 3 trial update assessing immunogenicity and safety of a 15-valent pneumococcal conjugate vaccine in healthy 2- to 3-month-old infants.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India [Phase 4]
A Phase 4 trial update describing the safety of the 13-valent pneumococcal conjugate vaccine in children aged 6 to 17 years in India; study …
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy volunteers aged 2 years and …
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers
A completed clinical trial update studying nasopharyngeal carriage in healthy Kenyan toddlers focusing on pneumococcal disease.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants [Phase 3]
Phase 3 study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in healthy infants completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and immunogenicity of a 10-valent pneumococcal conjugate vaccine (SIILPCV10) in healthy adults, toddlers, a…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Prevenar13 Drug Use Investigation - Adults Aged 65 Years or Older-
Clinical trial update for Prevenar13 in adults aged 65 and older; study status completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Evaluation of Pneumococcal Vaccine Coverage
This document reports the completion of a clinical trial evaluating pneumococcal vaccine coverage in immunocompromised individuals and those…
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants [Phase 2]
Phase 2 trial evaluating immunogenicity of a reduced primary vaccination schedule for a pneumococcal conjugate vaccine in UK infants; study …
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax) [Phase 1]
Phase 1 pediatric study evaluating the immune response to the 23-valent pneumococcal polysaccharide vaccine (Pneumovax 23) has completed, de…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM [NA]
Clinical trial update on SOP Toolkit implementation across diverse practices with results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Prevenar (13v) Infant Drug Use Investigation
A completed infant-use clinical trial of Pfizer's Prevnar 13 vaccine with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23) [Phase 3]
Phase 3 study evaluating immunological memory in children after a four-dose schedule of an 11-valent pneumococcal conjugate vaccine with a s…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Evaluation of Pneumococcal Vaccine Formulations in Young Adults [Phase 1]
Phase 1 trial evaluating pneumococcal vaccine formulations in young adults has completed. Sponsor: GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Post Market Surveillance to Observe Safety of Prevenar13™ in Adults
This document reports the completion of a post-market safety surveillance study for Prevnar 13 in adults, with results posted in 2017. It pr…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam [Phase 3]
Phase 3 trial update of GSK's pneumococcal vaccine in healthy infants in Vietnam has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™ [Phase 3]
Phase 3 trial updating primary vaccination with Synflorix or Prevnar 13 or both, and booster with Synflorix; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos
This study conducted safety surveillance of the Pneumococcal 13-valent Conjugate Vaccine (PCV13) in Filipinos, with results posted after com…